Annual Retained Earnings
-$274.39 M
-$36.06 M-15.13%
December 31, 2022
Summary
- As of February 24, 2025, ELOX annual retained earnings is -$274.39 million, with the most recent change of -$36.06 million (-15.13%) on December 31, 2022.
- During the last 3 years, ELOX annual retained earnings has fallen by -$137.37 million (-100.26%).
- ELOX annual retained earnings is now -1047182.44% below its all-time high of -$26.20 thousand, reached on June 30, 1997.
Performance
ELOX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$288.55 M
-$3.59 M-1.26%
September 30, 2023
Summary
- As of February 24, 2025, ELOX quarterly retained earnings is -$288.55 million, with the most recent change of -$3.59 million (-1.26%) on September 30, 2023.
- Over the past year, ELOX quarterly retained earnings has dropped by -$20.48 million (-7.64%).
- ELOX quarterly retained earnings is now -13015.95% below its all-time high of -$2.20 million, reached on December 31, 1999.
Performance
ELOX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ELOX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.1% | -7.6% |
| 3 y3 years | -100.3% | -74.4% |
| 5 y5 years | -604.3% | -235.0% |
ELOX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.1% | at low | -21.1% | at low |
| 5 y | 5-year | -100.3% | at low | -110.6% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Eloxx Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$288.55 M(+1.3%) |
| Jun 2023 | - | -$284.96 M(+1.5%) |
| Mar 2023 | - | -$280.62 M(+2.3%) |
| Dec 2022 | -$274.39 M(+15.1%) | -$274.39 M(+2.4%) |
| Sep 2022 | - | -$268.07 M(+2.9%) |
| Jun 2022 | - | -$260.56 M(+4.2%) |
| Mar 2022 | - | -$249.94 M(+4.9%) |
| Dec 2021 | -$238.32 M(+38.9%) | -$238.32 M(+5.3%) |
| Sep 2021 | - | -$226.23 M(+4.6%) |
| Jun 2021 | - | -$216.35 M(+20.0%) |
| Mar 2021 | - | -$180.29 M(+5.1%) |
| Dec 2020 | -$171.60 M(+25.2%) | -$171.60 M(+3.7%) |
| Sep 2020 | - | -$165.47 M(+4.2%) |
| Jun 2020 | - | -$158.85 M(+5.2%) |
| Mar 2020 | - | -$150.97 M(+10.2%) |
| Dec 2019 | -$137.02 M(+59.1%) | -$137.02 M(+9.3%) |
| Sep 2019 | - | -$125.39 M(+11.4%) |
| Jun 2019 | - | -$112.51 M(+14.7%) |
| Mar 2019 | - | -$98.06 M(+13.8%) |
| Dec 2018 | -$86.14 M(+121.1%) | -$86.14 M(+19.5%) |
| Sep 2018 | - | -$72.12 M(+18.3%) |
| Jun 2018 | - | -$60.96 M(+28.2%) |
| Mar 2018 | - | -$47.55 M(-61.4%) |
| Dec 2017 | -$38.96 M(-68.0%) | - |
| Sep 2017 | - | -$123.21 M(+1.1%) |
| Jun 2017 | - | -$121.82 M(+2.0%) |
| Jun 2017 | -$121.82 M(+5.4%) | - |
| Mar 2017 | - | -$119.45 M(+1.8%) |
| Dec 2016 | - | -$117.38 M(+0.7%) |
| Sep 2016 | - | -$116.57 M(+0.8%) |
| Jun 2016 | -$115.63 M(+7.9%) | -$115.63 M(+1.0%) |
| Mar 2016 | - | -$114.47 M(+2.8%) |
| Dec 2015 | - | -$111.38 M(+3.6%) |
| Sep 2015 | - | -$107.51 M(+0.3%) |
| Jun 2015 | -$107.18 M(+21.4%) | -$107.18 M(+1.6%) |
| Mar 2015 | - | -$105.48 M(+1.2%) |
| Dec 2014 | - | -$104.24 M(+11.5%) |
| Sep 2014 | - | -$93.48 M(+5.9%) |
| Jun 2014 | -$88.28 M(+18.6%) | -$88.28 M(+6.5%) |
| Mar 2014 | - | -$82.90 M(+6.5%) |
| Dec 2013 | - | -$77.87 M(+2.2%) |
| Sep 2013 | - | -$76.23 M(+2.4%) |
| Jun 2013 | -$74.43 M(+10.4%) | -$74.43 M(+2.8%) |
| Mar 2013 | - | -$72.43 M(+1.4%) |
| Dec 2012 | - | -$71.44 M(+1.8%) |
| Sep 2012 | - | -$70.15 M(+4.0%) |
| Jun 2012 | -$67.44 M(+11.0%) | -$67.44 M(+2.4%) |
| Mar 2012 | - | -$65.83 M(+2.3%) |
| Dec 2011 | - | -$64.35 M(+2.6%) |
| Sep 2011 | - | -$62.70 M(+3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2011 | -$60.75 M(+19.5%) | -$60.75 M(+5.1%) |
| Mar 2011 | - | -$57.80 M(+3.8%) |
| Dec 2010 | - | -$55.68 M(+3.4%) |
| Sep 2010 | - | -$53.86 M(+5.9%) |
| Jun 2010 | -$50.84 M(+41.4%) | -$50.84 M(+32.4%) |
| Mar 2010 | - | -$38.40 M(+16.0%) |
| Dec 2009 | - | -$33.11 M(+5.4%) |
| Sep 2009 | - | -$31.41 M(-12.6%) |
| Jun 2009 | -$35.95 M(+18.9%) | -$35.95 M(+4.6%) |
| Mar 2009 | - | -$34.36 M(+4.0%) |
| Dec 2008 | - | -$33.03 M(+5.2%) |
| Sep 2008 | - | -$31.40 M(+3.9%) |
| Jun 2008 | -$30.22 M(+18.0%) | -$30.22 M(+3.0%) |
| Mar 2008 | - | -$29.34 M(+7.5%) |
| Dec 2007 | - | -$27.30 M(+5.0%) |
| Sep 2007 | - | -$26.00 M(+1.5%) |
| Jun 2007 | -$25.62 M(+14.5%) | -$25.62 M(+2.9%) |
| Mar 2007 | - | -$24.91 M(+3.3%) |
| Dec 2006 | - | -$24.11 M(+4.9%) |
| Sep 2006 | - | -$22.97 M(+2.7%) |
| Jun 2006 | -$22.37 M(+17.4%) | -$22.37 M(+3.6%) |
| Mar 2006 | - | -$21.58 M(+3.4%) |
| Dec 2005 | - | -$20.87 M(+4.6%) |
| Sep 2005 | - | -$19.95 M(+4.7%) |
| Jun 2005 | -$19.05 M(+51.5%) | -$19.05 M(+33.3%) |
| Mar 2005 | - | -$14.29 M(+5.0%) |
| Dec 2004 | - | -$13.61 M(+3.7%) |
| Sep 2004 | - | -$13.13 M(+4.4%) |
| Jun 2004 | -$12.57 M(+32.4%) | -$12.57 M(+3.8%) |
| Mar 2004 | - | -$12.11 M(+3.6%) |
| Dec 2003 | - | -$11.70 M(+7.3%) |
| Sep 2003 | - | -$10.90 M(+14.7%) |
| Jun 2003 | -$9.50 M(+27.8%) | -$9.50 M(+5.2%) |
| Mar 2003 | - | -$9.02 M(+6.1%) |
| Dec 2002 | - | -$8.51 M(+7.1%) |
| Sep 2002 | - | -$7.95 M(+6.9%) |
| Jun 2002 | -$7.43 M(+35.3%) | -$7.43 M(+5.0%) |
| Mar 2002 | - | -$7.08 M(+7.3%) |
| Dec 2001 | - | -$6.60 M(+10.1%) |
| Sep 2001 | - | -$5.99 M(+9.1%) |
| Jun 2001 | -$5.49 M(+51.9%) | -$5.49 M(+8.2%) |
| Mar 2001 | - | -$5.08 M(+9.7%) |
| Dec 2000 | - | -$4.63 M(+12.3%) |
| Sep 2000 | - | -$4.12 M(+14.0%) |
| Jun 2000 | -$3.61 M(+209.1%) | -$3.61 M(+20.8%) |
| Mar 2000 | - | -$2.99 M(+36.0%) |
| Dec 1999 | - | -$2.20 M |
| Jun 1999 | -$1.17 M(+3094.0%) | - |
| Jun 1998 | -$36.60 K(+39.7%) | - |
| Jun 1997 | -$26.20 K | - |
FAQ
- What is Eloxx Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals annual retained earnings year-on-year change?
- What is Eloxx Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals quarterly retained earnings year-on-year change?
What is Eloxx Pharmaceuticals annual retained earnings?
The current annual retained earnings of ELOX is -$274.39 M
What is the all time high annual retained earnings for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high annual retained earnings is -$26.20 K
What is Eloxx Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, ELOX annual retained earnings has changed by -$36.06 M (-15.13%)
What is Eloxx Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of ELOX is -$288.55 M
What is the all time high quarterly retained earnings for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high quarterly retained earnings is -$2.20 M
What is Eloxx Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, ELOX quarterly retained earnings has changed by -$20.48 M (-7.64%)